Patents by Inventor Randall J. Gallaschun

Randall J. Gallaschun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted xanthines and methods of use thereof
    Patent number: 11958854
    Abstract: Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
    Type: Grant
    Filed: November 10, 2021
    Date of Patent: April 16, 2024
    Assignee: Hydra Biosciences, LLC
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun
  • SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF
    Publication number: 20230040259
    Abstract: Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
    Type: Application
    Filed: November 10, 2021
    Publication date: February 9, 2023
    Applicant: Hydra Biosciences, LLC
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun
  • Substituted xanthines and methods of use thereof
    Patent number: 11208409
    Abstract: Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
    Type: Grant
    Filed: April 29, 2019
    Date of Patent: December 28, 2021
    Assignee: Hydra Biosciences, LLC
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun
  • SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF
    Publication number: 20190322667
    Abstract: Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
    Type: Application
    Filed: April 29, 2019
    Publication date: October 24, 2019
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun
  • Substituted xanthines and methods of use thereof
    Patent number: 10399982
    Abstract: Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
    Type: Grant
    Filed: May 2, 2018
    Date of Patent: September 3, 2019
    Assignee: Hydra Biosciences, Inc.
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun
  • HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
    Publication number: 20190100491
    Abstract: The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of formula I: as defined in the specification. The invention is also directed to compositions containing and uses of the compounds of formula I.
    Type: Application
    Filed: September 6, 2018
    Publication date: April 4, 2019
    Inventors: Anton Franz Joseph, Fliri, Randall J. Gallaschun, Christopher John O'Donnell, Jacob Bradley Schwarz, Barbara Eileen Segelsein
  • SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF
    Publication number: 20180244674
    Abstract: Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
    Type: Application
    Filed: May 2, 2018
    Publication date: August 30, 2018
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun
  • Substituted xanthines and methods of use thereof
    Patent number: 9969736
    Abstract: Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: May 15, 2018
    Assignee: Hydra Biosciences, Inc.
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun
  • Substituted Xanthines and Methods of Use Thereof
    Publication number: 20170305910
    Abstract: Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
    Type: Application
    Filed: June 14, 2017
    Publication date: October 26, 2017
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun
  • Quinazoline-2,4(1 H,3H)-dione derivatives
    Patent number: 9745272
    Abstract: This invention relates to novel Quinazoline-2,4(1H,3H)-dione derivatives of Formula (I): and their use as TRPC5 modulators, pharmaceutical compositions containing the same, and methods of using the same as agents for the treatment of TRPC5 receptor mediated disorders or conditions. R1, R2, R3 and R4 have meanings given in the description.
    Type: Grant
    Filed: August 10, 2015
    Date of Patent: August 29, 2017
    Assignee: Hydra Biosciences, Inc.
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun
  • Thieno- and furo[2,3-d]pyrimidine-2,4[1H,3H]-dione derivatives
    Patent number: 9447114
    Abstract: This invention relates to novel Thieno- and Furo[2,3-d]pyrimidine-2,4[1H,3H]-dione derivatives of formula I and their use as TRPC5 modulators, pharmaceutical compositions containing the same, and methods of using the same as agents for the treatment of TRPC5 receptor mediated disorders or conditions. A, R1, R2, R3 and R4 have meanings given in the description.
    Type: Grant
    Filed: August 10, 2015
    Date of Patent: September 20, 2016
    Assignee: Hydra Biosciences, Inc.
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun
  • Pyrido[2,3-d]pyrimidine-2,4(1 H,3H)-dione derivatives
    Patent number: 9440972
    Abstract: This invention relates to novel Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione derivatives of Formula (I): and their use as TRPC5 modulators, pharmaceutical compositions containing the same, and methods of using the same as agents for the treatment of TRPC5 receptor mediated disorders or conditions. R1, R2, R3 and R4 have meanings given in the description.
    Type: Grant
    Filed: August 10, 2015
    Date of Patent: September 13, 2016
    Assignee: Hydra Biosciences, Inc.
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun
  • Pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione derivatives
    Patent number: 9440983
    Abstract: This invention relates to novel Pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione derivatives of Formula (I): and their use as TRPC5 modulators, pharmaceutical compositions containing the same, and methods of using the same as agents for the treatment of TRPC5 receptor mediated disorders or conditions. R1, R2, R3 R4 and R5 have meanings given in the description.
    Type: Grant
    Filed: August 10, 2015
    Date of Patent: September 13, 2016
    Assignee: Hydra Biosciences, Inc.
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun
  • Pyrido[3,4-d]pyrimidine-2,4(1H,3H)-dione derivatives
    Patent number: 9440973
    Abstract: This invention relates to novel Pyrido[3,4-d]pyrimidine-2,4(1H,3H)-dione derivatives of Formula (I): and their use as TRPC5 modulators, pharmaceutical compositions containing the same, and methods of using the same as agents for the treatment of TRPC5 receptor mediated disorders or conditions. R1, R2, R3 and R4 have meanings given in the description.
    Type: Grant
    Filed: August 10, 2015
    Date of Patent: September 13, 2016
    Assignee: Hydra Biosciences, Inc.
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun
  • SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF
    Publication number: 20160237089
    Abstract: Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
    Type: Application
    Filed: April 25, 2016
    Publication date: August 18, 2016
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun
  • Substituted xanthines and methods of use thereof
    Patent number: 9359359
    Abstract: Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: June 7, 2016
    Assignee: HYDRA BIOSCIENCES, INC.
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun
  • SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF
    Publication number: 20160145257
    Abstract: Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
    Type: Application
    Filed: January 30, 2016
    Publication date: May 26, 2016
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun, Spencer David Kimball
  • PYRIDO[2,3-d]PYRIMIDINE-2,4(1H,3H)-DIONE DERIVATIVES
    Publication number: 20160046624
    Abstract: This invention relates to novel Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione derivatives of Formula (I): and their use as TRPC5 modulators, pharmaceutical compositions containing the same, and methods of using the same as agents for the treatment of TRPC5 receptor mediated disorders or conditions. R1, R2, R3 and R4 have meanings given in the description.
    Type: Application
    Filed: August 10, 2015
    Publication date: February 18, 2016
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun
  • QUINAZOLINE-2,4(1H,3H)-DIONE DERIVATIVES
    Publication number: 20160039772
    Abstract: This invention relates to novel Quinazoline-2,4(1H,3H)-dione derivatives of Formula (I): and their use as TRPC5 modulators, pharmaceutical compositions containing the same, and methods of using the same as agents for the treatment of TRPC5 receptor mediated disorders or conditions. R1, R2, R3 and R4 have meanings given in the description.
    Type: Application
    Filed: August 10, 2015
    Publication date: February 11, 2016
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun
  • PYRROLO[3,2-d]PYRIMIDINE-2,4(3H,5H)-DIONE DERIVATIVES
    Publication number: 20160039831
    Abstract: This invention relates to novel Pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione derivatives of Formula (I): and their use as TRPC5 modulators, pharmaceutical compositions containing the same, and methods of using the same as agents for the treatment of TRPC5 receptor mediated disorders or conditions. R1, R2, R3 R4 and R5 have meanings given in the description.
    Type: Application
    Filed: August 10, 2015
    Publication date: February 11, 2016
    Inventors: Bertrand L. Chenard, Randall J. Gallaschun